June 20, 2017 (Medical News Today) Immunotherapy drugs continue to only be effective in about 10 to 30 percent of cancer patients with certain tumor types. A clue has been …
Targeting immune cells that help tumors stay hidden could improve immunotherapy Read More
February 16, 2016 (HealthDay News) Patient’s T cells are engineered with chimeric antigen receptors A new T-cell immunotherapy has led to sustained regression in many previously relapsing and treatment-resistant cases …
New Immune Tx Achieves Remission in B-Cell Malignancies Read More
Which condition has not been shown to respond to chimeric antigen receptor-engineered T cells (CAR-T cells) therapy? A. Non-Hodgkin lymphoma B. Acute lymphoblastic leukemia C. Chronic lymphocytic leukemia D. Meningioma …
StatPearls Question of the Week – #8 Read More
June 6, 2017 (HealthDay News) Findings from trial of chimeric antigen receptor T cells targeting B-cell maturation protein A new type of immunotherapy appears to provide long-lasting protection against multiple …
ASCO: CAR T-Cell Therapy Promising in Multiple Myeloma Read More
June 25, 2017 (VJHemOnc) CAR T-cells seem to be taking the hematology world by storm. Here. Rakesh Popat, MD, PhD from the University College London, London, UK talks to us …
VIDEO: Long and deep responses to CAR T-cell therapies in multiple myeloma Read More
June 12, 2017 (Medical News Today) A nanoparticle has been created by scientists at Johns Hopkins, supporting two unique antibodies that may have the power of “switching off” destructive properties …
“Immunoswitch” particles may be key to more-effective cancer immunotherapy Read More So far in the early clinical trials, chimeric antigen receptor-engineered T cells (CAR-T cells) have targeted which receptor in the treatment of acute lymphoblastic leukemia? A. CD5 B. CD19 C. …
StatPearls Question of the Week – #7 Read More
February 28, 2017 (Kite Pharma) See how CAR-T Therapy Works in this video from Kite Pharma.
VIDEO: CAR-T Therapy – How does it work? Read More
Tumor lysis syndrome (TLS) is another known and expected side effect of CAR T-cell therapy. TLS occurs due to cell death and sunsequent release of content into the bloodstream. Multiple …
CAR T-Cell Therapy HCP Guide – Side Effects: Tumor Lysis Syndrome Read More
One of the advantages of CAR T-cell therapy that targets the C19 tumor antigen is that C19 is not found on other cells except B cells, sparing other healthy tissues. …
CAR T-Cell Therapy HCP Guide – Side Effects: B Cell Aplasia Read More